Security Snapshot

INTUITIVE SURGICAL INC - Common Stock (ISRG) Institutional Ownership

CUSIP: 46120E602

13F Institutional Holders and Ownership History from Q1 2014 to Q2 2026

Latest Period

Q2 2026

Institutions Reporting

2,223

Shares (Excl. Options)

304,986,373

Price

$397.68

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0.07%
Share change
+9,068,081
Value change
+$3,513,717,651
Number of holders
2,223
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
355,159,132
SEC-reported price per share
$332.02
Insider filing price
$332.02
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • ISRG - INTUITIVE SURGICAL INC - Common Stock is tracked under CUSIP 46120E602.
  • 2223 institutions reported positions in Q2 2026.
  • 1 significant owner is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 2,310 to 2,223 between Q1 2026 and Q2 2026.
  • SEC-reported value moved from $136,807,205,181 to $121,594,042,269.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 2223 institutions filings for Q2 2026.

Open SEC evidence

Security key

46120E602

Latest holder period

Q2 2026

13F holders

2,223

13D/G owners

1

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
1
Security
ISRG
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
VANGUARD CAPITAL MANAGEMENT LLC 7.5% $12,413,286,162 26,601,419 Vanguard Capital Management 31 Mar 2026

As of 30 Jun 2026, 2,223 institutional investors reported holding 304,986,373 shares of INTUITIVE SURGICAL INC - Common Stock (ISRG). This represents 86% of the company’s total 355,159,132 outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
50%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 8.5% 30,024,648 -0.17% 0.18% $11,940,201,916
VANGUARD CAPITAL MANAGEMENT LLC 6.5% 23,131,099 +0.22% 0.2% $9,198,775,450
STATE STREET CORP 4.5% 16,063,040 +1.4% 0.19% $6,387,949,747
Invesco Ltd. 3.3% 11,843,563 +59% 0.37% $4,709,948,094
PRICE T ROWE ASSOCIATES INC /MD/ 3.2% 11,256,570 -10% 0.45% $4,476,514,000
GEODE CAPITAL MANAGEMENT, LLC 2.4% 8,534,767 +0.8% 0.18% $3,380,563,364
Capital World Investors 2.2% 7,742,681 -3.8% 0.36% $3,079,329,501
VANGUARD PORTFOLIO MANAGEMENT LLC 2% 7,243,264 +0.13% 0.13% $2,880,501,227
MORGAN STANLEY 1.8% 6,561,322 +8.3% 0.14% $2,609,308,152
NORGES BANK 1.4% 4,954,874 0.2% $1,970,454,292
FMR LLC 1.2% 4,251,130 -22% 0.07% $1,690,589,691
JPMORGAN CHASE & CO 1.2% 4,231,033 -7.9% 0.1% $1,717,673,063
Fisher Asset Management, LLC 1.1% 3,918,840 +1.7% 0.46% $1,558,444,582
WELLINGTON MANAGEMENT GROUP LLP 1.1% 3,802,003 -4% 0.26% $1,511,980,554
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 1.1% 3,744,497 +78% 0.66% $1,489,111,567
JENNISON ASSOCIATES LLC 1% 3,669,211 +21% 0.88% $1,459,171,817
ALLIANCEBERNSTEIN L.P. 1% 3,632,766 -4.7% 0.61% $1,674,668,799
NORTHERN TRUST CORP 0.99% 3,512,996 +0.25% 0.16% $1,397,048,249
BANK OF AMERICA CORP /DE/ 0.96% 3,403,759 -5.9% 0.09% $1,353,606,951
Bank of New York Mellon Corp 0.95% 3,358,863 -5.4% 0.22% $1,335,752,583
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC 0.92% 3,268,066 -1.5% 0.24% $1,299,644,485
GOLDMAN SACHS GROUP INC 0.81% 2,891,877 +18% 0.12% $1,150,041,824
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.79% 2,802,568 +6.8% 0.15% $1,114,525,243
Nuveen, LLC 0.76% 2,696,634 +2.9% 0.26% $1,072,397,277
Amundi 0.76% 2,685,598 +11% 0.26% $1,068,008,595

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
50
Latest
Q2 2026
Rows shown
1-25 of 50
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q2 304,986,373 $121,594,042,269 +$3,513,717,651 $397.68 2,223
2026 Q1 296,179,904 $136,807,205,181 -$3,297,384,433 $460.99 2,310
2025 Q4 298,657,256 $168,945,352,293 +$3,342,740,460 $566.36 2,403
2025 Q3 292,028,731 $130,254,355,689 -$5,828,754,642 $447.23 2,096
2025 Q2 302,212,870 $164,103,806,046 +$2,498,386,496 $543.41 2,239
2025 Q1 297,828,462 $147,452,497,410 -$2,920,638,650 $495.27 2,168
2024 Q4 303,187,590 $158,388,093,720 +$577,313,980 $521.96 2,110
2024 Q3 300,173,813 $147,375,603,417 -$1,552,730,520 $491.27 1,932
2024 Q2 303,379,619 $134,939,105,070 +$2,368,887,534 $444.85 1,801
2024 Q1 298,220,050 $118,921,599,882 +$1,531,564,281 $399.09 1,720
2023 Q4 295,650,122 $99,745,629,692 +$429,258,102 $337.36 1,661
2023 Q3 294,379,759 $86,004,667,518 -$556,389,854 $292.29 1,538
2023 Q2 293,728,647 $100,399,538,047 +$1,150,293,545 $341.94 1,533
2023 Q1 292,167,449 $74,609,737,827 -$322,787,328 $255.47 1,396
2022 Q4 294,224,979 $78,065,985,062 +$476,772,215 $265.35 1,413
2022 Q3 294,489,616 $55,297,156,896 -$267,694,633 $187.44 1,269
2022 Q2 295,634,259 $59,355,375,566 -$753,776,555 $200.71 1,299
2022 Q1 299,445,314 $90,277,385,945 -$175,204,516 $301.68 1,443
2021 Q4 300,090,509 $107,808,912,746 +$68,475,148,753 $359.30 1,501
2021 Q3 95,405,300 $94,845,072,771 -$1,431,185,121 $994.15 1,295
2021 Q2 100,969,651 $92,867,870,671 +$824,363,752 $919.64 1,313
2021 Q1 100,413,108 $74,216,852,097 -$940,447,395 $738.94 1,245
2020 Q4 101,760,120 $83,221,466,403 -$899,722,610 $818.10 1,237
2020 Q3 102,711,755 $72,826,965,266 +$120,708,821 $709.54 1,141
2020 Q2 102,456,598 $58,484,578,891 +$496,489,858 $569.83 1,034
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .